Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, which purpose is to provide a relative definition of high and low. This defintion is used to identify buy and sell signals and have proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. Get-A-Graph uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bottlenecks in bandwidth indicates a upcoming change. Break up through the moving average line, or continuously movements above the moving average line indicates a break up, and vice versa downwards.

Source: http://www.bollingerbands.com

Chart period: 2019-02-25 - 2019-05-23

Social Sentiment for NVAX

Today's data is from 5 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment 0.18

Will NVAX stock price go up or down on Tue, 28 May 2019?


Novavax Forecast and Stock Analysis

Technical NVAX stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-05-16 Loss -4.82%
Shorts n/a
Insider % n/a
Institutional % 45.00%
Beta 2.24
ROA -73.03%
Price to book n/a
P/E Ratio -0.65
Next Earnings Date 2019-08-07

Novavax gained 1.16% in the last trading day ( Thursday, 23rd May 2019 ), rising from $6.05 to $6.12 During day the stock fluctuated 4.61% from a day low at $5.90 to a day high of $6.17. The price has fallen in 6 of the last 10 days and is down by -14.88% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 418 779 more shares were traded than the day before. In total, 701 566 shares bought and sold for approximately $4.29 million.

Quick summary:

  • 30 day high of the NVAX stock price was $10.79 and low was $5.72.
  • 90 day high was $43.40 and low was $5.72.
  • 52 week high for the Novavax - $51.60 and low - $5.72.


Novavax lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $6.58 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -67.09% during the next 3 months and, with 90% probability hold a price between $-0.36 and $2.17 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Friday May 17, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Novavax holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $6.21 and $9.15. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 26 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Novavax finds support from accumulated volume at $6.04.

Support: $6.04 Price: $6.12 Resistance: $6.43


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.27 between high and low, or 4.61%. For the last week, the stock has had a daily average volatility of 7.45%.

Novavax is oversold on RSI14 (26). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

7.45 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Novavax holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Strong Sell Candidate Downgraded
Stronger Sell Today NVAX ranks #5290 as SELL CANDIDATE #5290 Weaker Sell
NVAX $6.12 ($0.07 1.16%)
NVAX is up $0.07 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for NVAX based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the NVAX analysis is free »

Will NVAX stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank